Relationship Between Fasting Plasma Glucagon Level and Renal Function-A Cross-Sectional Study in Individuals With Type 2 Diabetes
Related Experiment Video
Updated: Jan 31, 2026

Juxtasomal Biocytin Labeling to Study the Structure-function Relationship of Individual Cortical Neurons
Published on: February 25, 2014
Jian-Jun Liu1, Sylvia Liu1, Resham L Gurung1
1Clinical Research Unit, Khoo Teck Puat Hospital, Republic of Singapore.
Background And Aim:
The kidney is the main site for glucagon clearance. However, a recent study showed that hyperglucagonemia in patients with end-stage renal disease might not be caused by full-length intact glucagon. Additionally, the relationship between glucagon and renal function in early-stage chronic kidney disease (CKD) has not yet been characterized. We studied the association of fasting glucagon with renal function across a wide range of glomerular filtration rates (GFRs) in participants with type 2 diabetes.
Participants And Methods:
326 participants with type 2 diabetes and renal function spanning CKD stage 1 to 5 were included in the present cross-sectional study. Fasting full-length plasma glucagon was quantified using a newly developed ELISA (Mercodia AB, Uppsala, Sweden).
Results:
The fasting plasma glucagon level was elevated linearly from CKD stage 1 to 5 [from a median of 2.5 pM (interquartile range, 1.4 to 4.7) in CKD 1 to a median of 8.3 pM (interquartile range, 5.9 to 12.8) in CKD 5; P for trend < 0.0001], from as early as CKD stage 2 compared with that in stage 1 (Bonferroni-corrected P < 0.0001). The estimated GFR and homeostatic model of assessment-insulin resistance were the main determinants of the fasting glucagon level. These explained 14.3% and 10.3% of the glucagon variance, respectively. Albuminuria was not associated with fasting glucagon after adjustment for estimated GFR.
Conclusions:
Fasting full-length glucagon was elevated linearly with the deterioration in renal function in individuals with type 2 diabetes, even in those with early CKD. In addition to renal function, insulin sensitivity was also a main determinant of glucagon variance.
Insights
Fasting glucagon levels increase with worsening kidney function in type 2 diabetes patients, even in early chronic kidney disease (CKD). Insulin resistance also impacts glucagon levels.
Area of Science:
- Endocrinology
- Nephrology
- Metabolic Diseases
Background:
- The kidney is the primary site for glucagon clearance.
- Hyperglucagonemia in end-stage renal disease may not solely stem from intact glucagon.
- The relationship between glucagon and early chronic kidney disease (CKD) is not well-defined.
Purpose of the Study:
- To investigate the association between fasting glucagon and renal function across various glomerular filtration rates (GFRs).
- To examine glucagon levels in individuals with type 2 diabetes and differing stages of CKD.
Main Methods:
- Cross-sectional study of 326 participants with type 2 diabetes and CKD stages 1-5.
- Quantification of fasting full-length plasma glucagon using a novel ELISA.
Main Results:
- Fasting plasma glucagon increased linearly with CKD progression (CKD stage 1 to 5).
- Elevated glucagon was observed as early as CKD stage 2 compared to stage 1.
- Estimated GFR and insulin resistance were key determinants of fasting glucagon levels, explaining significant variance.
Conclusions:
- Fasting full-length glucagon levels rise with declining renal function in type 2 diabetes, including early CKD.
- Renal function and insulin sensitivity are primary factors influencing glucagon levels.
Related Concept Videos
Cross-Sectional Research
Profile Leveling and Cross Sections
Diabetes Mellitus: Type 2 and Gestational
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
Serum Studies: Renal Function Tests
Finding Volume Using Cross-Sectional Area

